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Background: Although the etiology of Type 1 Diabetes mellitus (T1DM) has not been determined, genetic
polymorphism in key genes, including SLC11A1, and association with Mycobacterium avium subspecies
paratuberculosis (MAP) have been reported. We hypothesize that molecular mimicry between MAP Heat shock
protein 65 K (Hsp65) and human Glutamic Acid Decarboxylase 65 K (GAD65) may be the trigger leading to
autoimmune destruction of beta cells in patients exposed to MAP.
Method: Peptide sequences of MAP Hsp65 and human GAD65 were investigated for amino acid sequence
homology and cross reactivity. A total of 18 blood samples from T1DM and controls were evaluated for the
presence of MAP.
Results: Peptide BLAST analysis revealed a 44% overall identity between MAP Hsp65 and GAD65 with 75% positives
in a 16 amino acid region. PyMOL 3D-structural analyses identified the same 16 amino acid region as a potential
epitope for antibody binding. Preliminary data suggests a cross reactivity between MAP Hsp65, and a healthy rat
pancreatic tissue homogenate against plasma from T1DM patients and rabbit polyclonal anti-MAP IgG. Long-term
culture of human blood resulted MAP detection in 3/10 T1DM and 4/8 controls whereas MAP IgG was detected in
5/10 T1DM samples and 3/8 non-diabetic controls.
Conclusion: The high degree of homology between GAD65 and MAP Hsp65 in an antigenic peptide region
supports a possible mycobacterial role in triggering autoimmune destruction of pancreatic cells in T1DM. Reactivity
of T1DM patient sera with MAP Hsp65 supports this finding. Culture of MAP from the blood of T1DM patients is
intriguing. Overall, the preliminary data are mixed and do not exclude a possible role for MAP in T1DM
pathogenesis. A larger study including well-characterized controls is needed to investigate the intriguing question
of whether MAP is associated with T1DM or not?
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Background
Type 1 diabetes mellitus (T1DM) is a chronic disease in
which the insulin producing beta cells of the pancreas
are selectively destroyed by T lymphocyte infiltration
[1-3]. It is the second most common chronic childhood
disease and accounts for 5 to 10% of all diabetic cases
[1]. According to the American Diabetes Association,* Correspondence: saleh.naser@ucf.edu
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reproduction in any medium, provided the orT1DM can be broadly classified into two forms: (a) type
1A is usually characterized by the presence of antibodies
against host proteins such as insulin, heat shock protein
60, insulinoma associated proteins (IA-2) and glutamic
acid decarboxylase (GAD65) and (b) type 1B which is
less frequent and has no known cause. GAD is a 65 KDa
enzyme that catalyzes the synthesis of gamma-amino bu-
tyric acid (GABA) by α-decarboxylation of L-glutamic
acid [4,5]. It is expressed in several tissues including
pancreatic islets where it is considered to be one of the
major auto-antigens involved in the pathogenesis of
T1DM. In fact, antibodies to GAD65 are routinely usedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cemia for prolonged periods leads to serious sequelae
such as diabetic nephropathy, diabetic neuropathy, dia-
betic retinopathy, cardiovascular ailments and stroke [1].
Insulin replacement therapy is the only symptomatic
treatment available for T1DM [1,6].
Genetic susceptibility for T1DM has been proposed.
Inherited susceptibility factors mainly include the HLA
genotypes DR and DQ and insulin-dependent diabetes
mellitus (IDDM) genes [1,7,8]. Though genetic predis-
position plays a major role in pathogenesis of T1DM,
concordance studies on monozygotic twins, the rising
incidence over the last 50 years and migrant studies sug-
gest that exogenous factors also pay an important role
[9]. Viruses, such as enterovirus and coxsackie, and
more recently bacteria such as Mycobacterium avium
subspecies paratuberculosis (MAP) have been proposed
as possible triggers for the autoimmune response
[10,11]. Dietary factors associated with T1DM include
consumption of cow’s milk, wheat protein and lack of
vitamin D [7,12]. The pathophysiology of T1DM is stu-
died using animal models such as non-obese diabetic
(NOD) mouse and Bio Breeding (BB) rat, but the trigger
for autoimmune-mediated tissue damage remains un-
known [13].
MAP has been proposed as a trigger for many auto-
immune diseases such as multiple sclerosis, autoimmune
thyroiditis, rheumatoid arthritis and autoimmune dia-
betes [14]. There is increasing evidence of shared genetic
susceptibility between T1DM and mycobacterial in-
fections which supports the role of MAP as a possible
trigger [6,15,16]. One example is the SLC11A1 (Solute
carrier 11a1) gene which encodes an integral membrane
protein of the lysosomes of monocytes and macrophages
[17]. During infection, the SLC11A1 causes acidification
of phagosomes which helps protect the host against
infection. Mutations in SLC11A1 lead to malfunction of
the protein, hampering phagosome acidification, leading
to a more hospitable environment for bacterial survival
and replication. Sechi et al. reported that polymorphisms
in SLC11A1 gene were associated with MAP infection in
T1DM patients in Sardinia [17]. The same group also
reported an elevated antibody response to MAP-specific
proteins such as MAP3733c and MAP3738c in Sardinian
T1DM patients [6,18].
Epitope homology between human antigens and MAP
proteins may serve as a trigger for activation of auto-
immunity [14,19,20]. Mycobacterial Hsp65 has been
implicated in autoimmune diseases such as rheumatoid
arthritis, autoimmune hepatitis, Kawasaki disease, scle-
roderma, Behcet disease and Takayasu’s arteritis [14].
MAP Hsp65 encodes 541 amino acids and Mtb Hsp65
encodes for 540 amino acids with both expressing an
estimated 65KDa protein (http://www.uniprot.org/). Wehypothesize that molecular mimicry between MAP
Hsp65 and human GAD65 might trigger an autoimmune
reaction targeting beta cells in pancreatic islets leading
to insulin deficiency and T1DM [9,10,14].
Results
Bioinformatic analyses of sequence homology between
MAP Hsp65 and GAD65
Although Mtb Hsp65 including its 3D-conformational
structure is well characterized, MAP Hsp65 is not [21].
BLAST analysis of the Mtb Hsp65 with MAP Hsp65
peptide sequences revealed 96% positive amino acids
with 94% amino acid identity (Figure 1). More import-
antly, a 44% identity was observed between MAP Hsp65
and human GAD65, with 75% positive amino acids in a
specific 16 amino acid region (Table 1). The homology
between Mtb Hsp65 and MAP Hsp65 within the 16
amino acid region was 100% (Table 1). The PyMOL
visualization tool was used to localize and identify the
same 16 amino acids peptide region in protein se-
quences of Mtb Hsp65 and human GAD65. As shown in
Figure 2, PyMOL analysis localized the 16 amino acid
epitope in human GAD65, and identified it as antigenic
site targeted by autoantibodies in T1DM [22].
Evaluation of antigenic cross reactivity between Mtb
Hsp65, MAP Hsp65 and GAD65
Blood from patient TD8 (subject with T1DM) was posi-
tive for MAP by culture and nested PCR (lane 8 Figure 3
and Table 2) and also for anti-MAP IgG (Table 2). Pre-
liminary data from immunoblot analysis suggests a cross
reactivity between Hsp65 from Mtb strain 25177, M.
avium strain 25291, clinical MAP isolate, E. coli recom-
binant clone of MAP Hsp65 designated pmptb20, and
pancreatic tissue lysate from a healthy rat using rabbit
polyclonal anti-MAP IgG (data not shown). Further-
more, plasma from TD8 reacted strongly with MAP pro-
teins (Table 2).
Detection of MAP DNA
Human blood samples were all negative for MAP DNA
in uncultured buffy coat preparations from all subjects
using direct nested IS900 PCR (Table 2). Following
6 months incubation, culture aliquots subjected to DNA
extraction and nested IS900 PCR revealed that MAP
DNA in 3/10 T1DM, 1/2 T2DM and 3/6 controls. As
shown in Figure 3, MAP DNA was detected in lanes 7, 8
and 18 (T1DM), lane 2 (T2DM) and lanes 10, 13 and 17
(controls). Table 3 summarizes the PCR results in all
samples.
Detection of MAP IgG antibodies
A commercial ELISA kit (IDEXX Laboratories, Inc.,
Westbrook, ME) used for diagnosis of Paratuberculosis
Figure 1 BLAST analysis between Mtb Hsp65 and MAP Hsp65 peptide sequences. Query peptide sequence is Mycobacterium tuberculosis
Heat Shock protein 65(P0A520). Subject peptide sequence is Mycobacterium paratuberculosis Heat Shock Protein 65 (P42384).
Table 1 BLAST analysis between MAP Hsp65, Mtb Hsp65








+ER + ++L+ VIKA 75%
MAP Hsp65 364-379 QERLAKLAGGVAVIKA
QERLAKLAGGVAVIKA 100%
Mtb Hsp65 364-379 QERLAKLAGGVAVIKA
a: Sequence identity between MAP Hsp65 and Mtb Hsp65 is 100% within this 16
amino acid region and 75% between GAD65 and both mycobacterial protein.
Abbreviations: GAD65 Glutamic Acid Decarboxylase, MAP Mycobacterium avium
subspecies paratuberculosis, Mtb Mycobacterium tuberculosis, Hsp65 Heat shock
protein of 65 kDa.
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anti-MAP IgG in plasma from all samples used in this
study. The analysis was repeated twice and the average
of all attempts was reported. As shown in Table 2 and
Table 3, MAP antibodies were detected in 3/8 (37.5%)
controls compared to 5/10 (50%) T1DM samples.
Discussion
Association of MAP with T1DM has been reported
exclusively in Sardinia, Italy and by Sechi et al.
[6,15-18,25,26]. In the present study, we explored the
possibility of MAP Hsp65 as a possible trigger for auto-
destruction of beta cells through cross-reactivity with
GAD65. BLAST analysis between MAP Hsp65 and hu-
man GAD65 revealed a 16 amino acid region with 75%
positive amino acid sequence (Table 1). Interestingly, the
same 16 amino acid region in GAD65 was previously
BA
Figure 2 PyMOL structural analysis of Mtb Hsp65 and human
GAD65. A: Protein structure of human GAD65 PDB ID: 2OKK [23]
B: Protein structure of Mtb Hsp65 PDB ID:3RTK [24]. Highlighted
regions represent the amino acids that were identical between
GAD65 and MAP Hsp65 by BLAST analysis. Mtb Hsp65 and MAP
Hsp65 are 100% homologous in this 16 amino acid region.
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to auto destruction of pancreatic beta cells [22]. Since
the PyMOL 3D structure of MAP Hsp65 is not available,
the available peptide sequence of the closely related Mtb
Hsp65 was used. In fact, the two heat-shock proteins
have an overall amino acid identity of 94%, and 100%
identity in the specific 16 amino acid region in question
(Table 1). Figure 2 suggests that the 16 amino acid site
localized on the 3D structure of MAP Hsp65 may pro-
voke antibodies following MAP infection. The anti-MAP
Hsp65 antibodies may then bind to the GAD65 epitope
on the surface of Beta cell leading to their destruction.
Preliminary immunohistochemistry data supports this
hypothesis.
Detection of anti-MAP IgG in plasma from T1DM
subjects (Table 3) is significant. More importantly is the
detection of MAP DNA in blood culture obtained from
T1DM subjects despite the fastidious nature of MAP.
The detection of MAP in one of the two type 2 diabetes
patients may be the results of disease misdiagnosis or
the possibility of co-infection with other MAP-associateddiseases. The same argument may be made for detection
of MAP in uncharacterized controls.
The data partially corroborate the findings of Sechi
et al. [6,15-18,25,26] and indicate that further study is
needed. A larger study which includes well characterized
controls is needed to appropriately evaluate a possible
role of MAP in T1DM in other geographic regions.
Molecular mimicry causing cross reactivity between
MAP Hsp65 and human GAD65 may play a role in the




Protein BLAST analysis was initialized to determine the
sequence homology between peptide sequences of MAP
Hsp65 and human GAD 65 (http://blast.ncbi.nlm.nih.
gov/Blast.cgi). The peptide sequences of the proteins for
the analysis were retrieved from Uniprot protein database
(http://www.uniprot.org/). Predicted protein structures for
PyMOL analysis were retrieved from the protein data
bank (http://www.rcsb.org/pdb/home/home.do) and were
used to localize the homologous sequences of the proteins
in their 3D conformation.
Evaluation of cross reactivity between Mtb Hsp65, MAP
Hsp65 and GAD 65
Immunoblot analysis
Immunoblot analysis was used to evaluate the cross
reactivity between MAP Hsp65 and human GAD65
following standard method [21].
Clinical samples
Blood samples were collected from 18 subjects. The
demographic information including gender and diagno-
sis are listed in Table 2. Ten samples were collected
from subjects with T1DM, 2 from subjects with Type 2
diabetes mellitus (T2DM) and from 6 non-diabetic con-
trols. All subjects were free from inflammatory bowel
disease. Informed consent was obtained from subjects in
accordance with the Institutional Review Board (IRB)
regulations. K2 EDTA-blood samples were collected and
coded to mask patient identity and disease status.
Isolation of peripheral leukocytes
The K2 EDTA-blood tubes were transported to the la-
boratory cold within 24 hours. The blood was processed
by centrifugation at 3000 × g for 10 minutes at room
temperature. A volume of 1 mL of plasma was trans-
ferred to a new sterile tube and stored at −70°C for
future testing for anti-MAP IgG, anti-GAD IgG, The
leukocyte containing buffy coat layer was carefully trans-
ferred to a new sterile tube. Leukocytes were then mixed
with two volumes of red blood cell lysis buffer (Roche
Figure 3 Nested PCR detection of MAP DNA in blood culture. Two rounds of nested PCR consisting of first set using P90/91 oligonucleotide
primers and second round set using AV1/AV2 oligonucleotides primers. PCR product of 298 base pair indicates positive result for MAP. M:
Molecular weight marker in base pair. =: Negative control for second round of PCR. -: Negative control for first round of PCR. TE: Negative control
for DNA extraction. +: DNA template from MAP strain UCF4 as a positive control. Lanes 1 to 18: correspond with the code of each blood sample
used in this study. Codes with a prime (‘) indicate that 1 uL of PCR product from P90/91 PCR set was used as template for the second AV1/AV2
round of PCR whereas codes without prime indicate that 23 uL of PCR product from P90/91 PCR set was used as template.
Table 2 Demographic information and MAP results for clinical samples used in this study
Presence of MAPa
Code Sex Diagnosisb Sourcec Specimen Direct PCRd Culturee Anti-MAP IgGf
TD 3 F T1DM UF Whole Blood negative negative positive
TD 4 M T1DM UF Whole Blood negative negative positive
TD 5 F T1DM UF Whole Blood negative negative positive
TD 6 M T1DM UF Whole Blood negative negative positive
TD 7 M T1DM UF Whole Blood negative positive negative
TD 8 F T1DM UF Whole Blood negative positive positive
TD 9 M T1DM UF Whole Blood negative negative negative
TD 14 F T1DM UF Whole Blood negative negative negative
TD 15 M T1DM UF Whole Blood negative negative negative
TD 18 F T1DM UF Whole Blood negative positive negative
TD 1 M T2DM UF Whole Blood negative negative negative
TD 2 M T2DM UF Whole Blood negative positive negative
TD 10 F CONTROL UF Whole Blood negative positive negative
TD 11 F CONTROL UF Whole Blood negative negative negative
TD 12 F CONTROL UF Whole Blood negative negative negative
TD 13 F CONTROL UF Whole Blood negative negative positive
TD 16 F CONTROL UF Whole Blood negative negative negative
TD 17 M CONTROL UF Whole Blood negative positive positive
a: MAP Mycobacterium avium subspecies paratuberculosis.
b: T1DM Type I Diabetes Mellitus, T2DM Type two Diabetes Mellitus.
c: UF University of Florida.
d: direct PCR: nested PCR was performed on DNA extracts from uncultured peripheral leukocytes.
e: culture: nested PCR was performed on DNA extracts from 6 months old culture of peripheral leukocytes.
f: anti-MAP IgG: IDEXX serologic kit was used to measure anti-MAP IgG titer.
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Table 3 Summary of results of clinical analysis of human
samples
MAP Anti-MAP IgG
T1DM 3/10 (30%) 5/10 (50%)
T2DM 1/2 (50%) 1/2 (50%)
CONTROL 3/6 (50%) 2/6 (33.33%)
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were then centrifuged at 2500 × g rpm for 5 minutes at
room temperature. The supernatant was discarded and
the leukocyte pellet was either inoculated into culture
media or stored at −20°C for further use [27].
Culture of peripheral leukocytes
The purified buffy coat cells were inoculated into
Mycobacterial Growth Indicator Tubes (MGIT) ParaTB
Medium™ (BD Diagnostic Systems, Sparks, MD). Each
tube of MGIT ParaTB medium was supplemented with
800 μl of OADC supplement (BD Diagnostic Systems,
Sparks, MD) and 500 μl of egg yolk enrichment (BD
Diagnostic Systems, Sparks, MD). All tubes were incu-
bated at 37°. Following 6 months incubation, culture
aliquots were subjected to DNA extraction and nested
IS900 PCR analysis.
DNA extraction from peripheral leukocytes
The isolated uncultured leukocytes were re-suspended
in Tris EDTA (TE) buffer and then subjected to genomic
DNA extraction following Naser et al. method [27].
Nested PCR for MAP DNA detection
DNA extracts were subjected to nested IS900 PCR ana-
lysis [27]. The first round of PCR reaction mixture con-
sists of 25 μl of Master Mix (50units/ml- TaqDNA
polymerase, 400 μM-each dATP, dGTP, dCTP, dTTP and
3 mM MgCl2; Promega, Madison, WI, USA), 1 μl of each
primer (Forward primer: P90-5′-GTTCGGGGCCGTCG
CTTAGG-3′, Reverse primer: P91-5′-GAGGTCGATC
GCCCACGTGA-3′) and 23 μl of DNA template. In the
second round of PCR reaction there was two sets of reac-
tions which differed by the volume of the DNA template
used. First set of the reaction mixture consisted of 25 μl of
Master Mix, 1 μl of each primer (Forward primer: AV1-5′
ATGTGGTTGCTGTGTTGGATGG’3, Reverse primer:
AV2-5′CCGCCGCAATCAACTCCAG 3′) and 23 μl of
DNA template which is the PCR product of the first
round of reaction. The second set of the reaction mixture
consists of the same except that 1 μl of PCR product from
the first reaction was used as a template and the total vol-
ume was made to 50 μl by addition of nuclease free water.
The cycle conditions of the primary reaction were: 95°C
for 5 min, 35 cycles of 95°C for 1 min, 58°C for 1.5 min,
72°C for 1.5 min and final extension of 10 min at 72°C.The cycle conditions of the secondary reaction were: 95°C
for 5 min, 35 cycles of 95°C for 0.5 min, 60°C for 0.5 min,
72°C for 1 min and final extension of 10 min at 72°C. The
PCR product was analyzed on 2% agarose gel.
Detection of MAP IgG antibodies
The IDEXX MAP antibody test kit (IDEXX Laborator-
ies, Westbrook, ME, USA) was modified for measure-
ment of anti-MAP IgG levels in human samples.
Plasma was diluted fifty fold (1:50) with the sample
diluents. HRP-conjugated rabbit anti-human IgG was
used at a final concentration of 1:100. Assays were
performed in duplicate and reported as described by
the manufacturer.
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